A systematic approach for developing a corpus of patient reported adverse drug events: a case study for SSRI and SNRI medications M Zolnoori, KW Fung, TB Patrick, P Fontelo, H Kharrazi, A Faiola, YSS Wu, ... Journal of biomedical informatics 90, 103091, 2019 | 50 | 2019 |
The PsyTAR dataset: From patients generated narratives to a corpus of adverse drug events and effectiveness of psychiatric medications M Zolnoori, KW Fung, TB Patrick, P Fontelo, H Kharrazi, A Faiola, ... Data in brief 24, 103838, 2019 | 41 | 2019 |
Beta-carotene/cyclodextrin-based inclusion complex: improved loading, solubility, stability, and cytotoxicity M Yazdani, O Tavakoli, M Khoobi, YS Wu, MA Faramarzi, E Gholibegloo, ... Journal of Inclusion Phenomena and Macrocyclic Chemistry 102 (1), 55-64, 2022 | 40 | 2022 |
Bayesian estimation of vancomycin pharmacokinetics in obese children: matched case-control study J Le, EV Capparelli, U Wahid, YSS Wu, GL Romanowski, TM Tran, ... Clinical therapeutics 37 (6), 1340-1351, 2015 | 35 | 2015 |
Migalastat Tissue Distribution: Extrapolation From Mice to Humans Using Pharmacokinetic Modeling and Comparison With Agalsidase Beta Tissue Distribution in Mice YS Wu, R Khanna, V Schmith, Y Lun, JS Shen, A Garcia, L Dungan, ... Clinical pharmacology in drug development 10 (9), 1075-1088, 2021 | 15 | 2021 |
Identifying the Underlying Factors Associated With Patients’ Attitudes Toward Antidepressants: Qualitative and Quantitative Analysis of Patient Drug Reviews M Zolnoori, KW Fung, P Fontelo, H Kharrazi, A Faiola, YSS Wu, V Stoffel, ... JMIR mental health 5 (4), e10726, 2018 | 10 | 2018 |
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic model J Zhu, YS Wu, RJ Beechinor, R Kemper, LH Bukkems, RAA Mathôt, ... Haemophilia 27 (6), 974-983, 2021 | 3 | 2021 |
External evaluation of two pediatric population pharmacokinetics models of oral trimethoprim and sulfamethoxazole YSS Wu, M Cohen-Wolkowiez, CP Hornik, JG Gerhart, J Autmizguine, ... Antimicrobial agents and chemotherapy 65 (7), e02149-20, 2021 | 3 | 2021 |
Development of an Adverse Drug Reaction Corpus from Consumer Health Posts M Zolnoori, TB Patrick, KW Fung, A Faiola, YSS Wu, J Zhu, C Eldredge | 1 | 2017 |
Population Pharmacokinetics of Oral Migalastat in Adolescents and Adults With and Without Renal Impairment C Leonowens, V Schmith, J Zhou, YS Wu, V Ivaturi, FK Johnson Clinical Pharmacology in Drug Development 11 (12), 1367-1381, 2022 | | 2022 |